Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-01-03
1995-10-24
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514953, 514962, A61K 3156
Patent
active
054610427
ABSTRACT:
The present invention provides an improved compositions and methods for regulating the immune response, for ameliorating effects of stress, and for avoiding untoward effects of chemotherapy or exposure to irradiation by administration of androstenediol (AED) and androstenetriol (AET). The improved means of regulating immune response can be utilized in treating infectious diseases and immune diseases such as diabetes and chronic fatigue syndrome, both diseases now considered to be immune response related syndromes.
REFERENCES:
patent: 2170124 (1939-06-01), Butenandt et al.
patent: 2521586 (1950-09-01), Levy et al.
patent: 4279532 (1990-08-01), El-Rashidy
patent: 4435327 (1984-03-01), Petzoldt et al.
patent: 5077284 (1991-12-01), Loria et al.
patent: 5206008 (1993-04-01), Loria
patent: 5277907 (1994-01-01), Loria
Butenandt, et al, Ber., (1938) 1316-1322.
Gates Stephen
Hendricks Glenna
Henley III Raymond
Weddington K.
LandOfFree
Regulation of the immune system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of the immune system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of the immune system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1886744